Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of SHC014748M in relapsed or refractory follicular lymphoma and marginal zone lymphoma
CTR20200443Phase 2Active
- Sponsor
- Shenghe Pharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shc014748m in follicular lymphoma (FL), marginal zone B-cell lymphoma (MZL), sponsored by Shenghe Pharmaceutical. Started Jul 2020; status: active.
02
Drugs
shc014748m
03
Conditions
follicular lymphoma (FL)marginal zone B-cell lymphoma (MZL)
Beyond the preview
Go deeper on CTR20200443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200443.